{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16724", "batch_size": 200, "batch_pos": 64, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency verb, potent metaphor, or other Q2 cue found.", "method": "llm_batch", "batch_id": "batch_2_17180", "batch_size": 200, "batch_pos": 56, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"hop_idx": 3, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_3_19240", "batch_size": 200, "batch_pos": 28, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with explicit scale or impact information.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_3_19240_r1", "batch_size": 200, "batch_pos": 28, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_19960", "batch_size": 200, "batch_pos": 27, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports a timeline for testing, not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_17680", "batch_size": 200, "batch_pos": 26, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment discusses testing timelines but does not use a minimiser in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_18468", "batch_size": 200, "batch_pos": 5, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_16576", "batch_size": 200, "batch_pos": 197, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes a plan/future possibility: 'late-stage testing would begin in 2025'.", "method": "llm_batch", "batch_id": "batch_8_13884", "batch_size": 200, "batch_pos": 113, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
